The rise of "Ozempic Face": Analyzing trends and treatment challenges associated with rapid facial weight loss induced by GLP-1 agonists

J Plast Reconstr Aesthet Surg. 2024 Sep:96:225-227. doi: 10.1016/j.bjps.2024.07.051. Epub 2024 Jul 25.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Face
  • Female
  • Glucagon-Like Peptide 1 / agonists
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use
  • Male
  • Middle Aged
  • Semaglutide
  • Weight Loss* / drug effects

Substances

  • Glucagon-Like Peptide 1
  • Hypoglycemic Agents
  • Semaglutide